1007 related articles for article (PubMed ID: 25621825)
1. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.
Robinette ML; Fuchs A; Cortez VS; Lee JS; Wang Y; Durum SK; Gilfillan S; Colonna M;
Nat Immunol; 2015 Mar; 16(3):306-17. PubMed ID: 25621825
[TBL] [Abstract][Full Text] [Related]
2. Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow.
Walker JA; Clark PA; Crisp A; Barlow JL; Szeto A; Ferreira ACF; Rana BMJ; Jolin HE; Rodriguez-Rodriguez N; Sivasubramaniam M; Pannell R; Cruickshank J; Daly M; Haim-Vilmovsky L; Teichmann SA; McKenzie ANJ
Immunity; 2019 Jul; 51(1):104-118.e7. PubMed ID: 31128961
[TBL] [Abstract][Full Text] [Related]
3. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
[TBL] [Abstract][Full Text] [Related]
4. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer.
Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D
Front Immunol; 2022; 13():914266. PubMed ID: 35720280
[TBL] [Abstract][Full Text] [Related]
5. Developmental options and functional plasticity of innate lymphoid cells.
Lim AI; Verrier T; Vosshenrich CA; Di Santo JP
Curr Opin Immunol; 2017 Feb; 44():61-68. PubMed ID: 28359987
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells.
Bennstein SB; Scherenschlich N; Weinhold S; Manser AR; Noll A; Raba K; Kögler G; Walter L; Uhrberg M
Stem Cells Transl Med; 2021 Jun; 10(6):867-882. PubMed ID: 33475258
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA-seq identifies a PD-1
Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P
Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818
[TBL] [Abstract][Full Text] [Related]
8. Identification of innate lymphoid cells in single-cell RNA-Seq data.
Suffiotti M; Carmona SJ; Jandus C; Gfeller D
Immunogenetics; 2017 Jul; 69(7):439-450. PubMed ID: 28534222
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
11. [Innate lymphoid cells].
Crinier A; Viant C; Girard-Madoux M; Vivier É
Med Sci (Paris); 2017 May; 33(5):534-542. PubMed ID: 28612730
[TBL] [Abstract][Full Text] [Related]
12. Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells.
Ebihara T
Cells; 2020 May; 9(5):. PubMed ID: 32403291
[TBL] [Abstract][Full Text] [Related]
13. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
14. The role of ILC subsets in cancer.
Bruchard M; Spits H
Semin Immunol; 2022 Nov; 61-64():101654. PubMed ID: 36306660
[TBL] [Abstract][Full Text] [Related]
15. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
16. Development of human natural killer cells and other innate lymphoid cells.
Montaldo E; Vacca P; Moretta L; Mingari MC
Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
[TBL] [Abstract][Full Text] [Related]
17. The Development and Diversity of ILCs, NK Cells and Their Relevance in Health and Diseases.
Zhang Y; Huang B
Adv Exp Med Biol; 2017; 1024():225-244. PubMed ID: 28921473
[TBL] [Abstract][Full Text] [Related]
18. CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
Chen L; Youssef Y; Robinson C; Ernst GF; Carson MY; Young KA; Scoville SD; Zhang X; Harris R; Sekhri P; Mansour AG; Chan WK; Nalin AP; Mao HC; Hughes T; Mace EM; Pan Y; Rustagi N; Chatterjee SS; Gunaratne PH; Behbehani GK; Mundy-Bosse BL; Caligiuri MA; Freud AG
Immunity; 2018 Sep; 49(3):464-476.e4. PubMed ID: 30193847
[TBL] [Abstract][Full Text] [Related]
19. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.
Luci C; Vieira E; Perchet T; Gual P; Golub R
Front Immunol; 2019; 10():1192. PubMed ID: 31191550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
